stockrowCabot Corporation
CBT Basic Materials Specialty Chemicals
Cabot Corporation’s revenue for fiscal 2025 (year ended September 2025) was $3.7 billion, down 7.04% from fiscal 2024.
- Revenue
- +12.2%
- EPS
- +79.4%
- Free cash flow
- −51.7%
- Total debt
- +10.8%
Quarter to September 2026, against a year earlier
Follow CBT
Alert me
Cabot Corporation (CBT) Return on assets
Cabot Corporation's return on assets over the twelve months to 30 September 2026 was 5.41%, down 3.4 percentage points from fiscal 2025 (8.77%). Over the past ten years it has ranged from −9.33% (fiscal 2015) to 12.5% (fiscal 2023); the current reading is higher than 82% of that period. That is above the Specialty Chemicals industry median of 0.45% and above the Basic Materials sector median of 0.00%.
Return on assets, annual
Embed this chart
Annual newest first
| Period | Return on assets | Change (points) |
|---|---|---|
| FY2025 | 8.77% | (1.58) |
| FY2024 | 10.4% | (2.13) |
| FY2023 | 12.5% | 6.36 |
| FY2022 | 6.12% | (2.09) |
| FY2021 | 8.21% | 16.44 |
| FY2020 | −8.23% | (13.26) |
| FY2019 | 5.03% | 8.49 |
| FY2018 | −3.46% | (11.24) |
| FY2017 | 7.78% | 3.00 |
| FY2016 | 4.78% | 14.11 |
Against its own ten years
Return on assets against peers
| Company | Return on assets |
|---|---|
| WDFC WD-40 Company compare | 16.9% |
| HWKN Hawkins, Inc. compare | 8.60% |
| SXT Sensient Technologies Corporation compare | 7.23% |
| CBT Cabot Corporation | 5.41% |
| FUL H. B. Fuller Company compare | 3.73% |
| AVNT Avient Corporation compare | 3.00% |
| PRM Perimeter Solutions, SA compare | 1.84% |
| ASH Ashland Inc. compare | 0.09% |
| CLMT Calumet, Inc. compare | −4.90% |
| Specialty Chemicals industry median | 0.45% |
| Basic Materials sector median | 0.00% |
| Market median | 0.00% |
What Return on assets is
ROA tells an investor how much profit a company earns for shareholders from the assets it uses to run its business.
Annual: Net Income Allotted to Shareholders ÷ Average Assets; TTM: Net Income Allotted to Shareholders ÷ Average Assets (latest quarter)
More on CBT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement